GRPR and Its Role in Lung Cancer Metastasis
Author Information
Author(s): Kim Dong-Gun, Choi Eun-Young, Ahn Hye-Mi, Kim Youn-Jae
Primary Institution: National Cancer Center, Republic of Korea
Hypothesis
This study aimed to investigate the function and underlying mechanisms of GRPR in lung adenocarcinoma metastasis.
Conclusion
The study suggests that GRPR could serve as both a prognostic marker and a therapeutic target to inhibit metastasis in lung adenocarcinoma.
Supporting Evidence
- GRPR levels were significantly elevated in tumor tissues.
- Higher GRPR expression was associated with worse overall survival outcomes.
- GRPR overexpression enhanced LUAD cell invasion.
- GRPR knockdown inhibited invasion both in vitro and in vivo.
- CRABP2 and FNDC4 were identified as key targets in GRPR-overexpressing cells.
Takeaway
This study found that a protein called GRPR helps lung cancer spread, and blocking it might help treat the disease.
Methodology
The study used RNA sequencing, gene set enrichment analysis, and various in vitro and in vivo assays to evaluate GRPR's role in lung adenocarcinoma.
Limitations
The association between the GRPR-CRABP2/FNDC4 axis and LUAD metastasis has not been validated in vivo.
Participant Demographics
The study analyzed data from lung adenocarcinoma patients, including a sample size of 181.
Statistical Information
P-Value
3.4 × 10−3
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website